文献速递骨肌技术与安全US

基于超声影像的卷积神经网络框架用于浅表软组织肿块多分类的开发和验证

Development and Validation of a Convolutional Neural Network Framework Based on Ultrasound Imaging for Multi-Classification of Superficial Soft Tissue Masses.
PubMed 文献 · Acad Radiol · 2026-09-07

本研究基于四家机构3168例浅表软组织肿块患者的超声图像,开发并验证了多任务卷积神经网络框架ST-USNet。该框架可鉴别良恶性、恶性亚型、侵袭性与惰性淋巴瘤并初步探索转移癌来源。在独立测试队列中性能略有下降但仍有效,作为辅助工具可提升放射科医生诊断准确性。

要点

  • ST-USNet对浅表软组织肿块良恶性鉴别的验证队列AUC为0.984,可用于辅助初筛。
  • 恶性亚型分类中肉瘤、淋巴瘤、转移癌的验证队列AUC分别为0.932、0.909、0.922。
  • 作为辅助工具时,ST-USNet可提高低年资和高年资放射科医生的诊断准确性。

核心结论

  • ST-USNet在临床肿瘤学中是一种有效且实用的浅表软组织肿块分类决策支持系统。
  • ST-USNet在独立测试队列上性能略有下降但仍保持有效。
  • ST-USNet在全部分类任务中显著优于高年资放射科医生或与其表现相当。

研究设计与样本

  • 患者中位年龄为58岁,四分位距为46至68岁。
  • 在独立测试队列上评估ST-USNet性能,并与放射科医生表现进行McNemar检验比较。

关键影像表现/征象

  • ST-USNet基于手动勾画的感兴趣区对浅表软组织肿块超声图像进行分类。
  • ST-USNet由四个子模型组成:SM-1、SM-2、SM-a和SM-b。

诊断标准与关键数值

  • SM-1鉴别恶性与良性浅表软组织肿块的验证队列AUC为0.984。
  • SM-2分类恶性亚型的验证队列AUC:肉瘤为0.932,淋巴瘤为0.909,转移癌为0.922。
  • SM-a区分侵袭性与惰性淋巴瘤的验证队列AUC为0.951。
  • SM-b初步探索转移癌来源系统,包括甲状腺、乳腺、呼吸、消化和生殖系统,因样本量有限,结果仅为探索性。
  • 初步读片研究中4名放射科医生评估85例,ST-USNet显著优于高年资医生(p=0.012)或表现相当(p=0.267、0.092、0.332)。

临床应用与阅片要点

  • ST-USNet可作为辅助工具用于浅表软组织肿块的日常超声报告,帮助规范良恶性初步判断。
  • 对手动勾画感兴趣区的依赖性提示临床应用中需注意ROI勾画的一致性和质量。

局限性

  • SM-b对转移癌来源的识别因样本量有限,结果仅为探索性。
  • 原文要求临床部署前需进行多中心前瞻性验证和持续模型更新。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: Superficial soft tissue masses (STMs) represent a diagnostic dilemma in clinical practice, with ultrasound (US) being the front-line imaging modality available globally. However, the high complexity of STMs in imaging makes subjective evaluation highly dependent on experience, frequently causing inconsistent malignancy assessments. This inconsistency triggers unnecessary benign biopsies and delays treatment for malignant STMs. We developed ST-USNet, a multitask convolutional neural network framework to classify superficial STMs based on manually drawn regions of interest.

MATERIALS AND METHODS: This retrospective study included US images of 3168 patients (median age, 58 years; IQR, 46-68 years) with STMs from four institutions between March 2015 and October 2024. The ST-USNet was developed and validated on multi-center data. Its performance was then evaluated on a separate, independent test cohort. The diagnostic performance of ST-USNet was compared with that of radiologists using McNemar tests.

RESULTS: The ST-USNet was composed of four sub-models (SM-1, SM-2, SM-a, and SM-b). In the validation cohort, SM-1 was trained to distinguish malignant from benign STMs (AUC: 0.984); SM-2 was to classify the malignant STM subtypes including sarcoma, lymphoma, and metastatic carcinoma (AUC: 0.932, 0.909, 0.922); SM-a was to discriminate between aggressive and indolent lymphoma (AUC: 0.951). SM-b was designed to explore the identification of metastatic carcinoma origin (thyroid, breast, respiratory, digestive, and reproductive systems) as a preliminary analysis; however, due to limited sample sizes, these results should be interpreted as exploratory. ST-USNet achieved high AUCs on the validation cohort and remained effective, albeit with slightly lower performance, on an independent test cohort. In a preliminary reader study (4 radiologists, 85 cases), ST-USNet either significantly outperformed senior radiologists (p = 0.012) or performed comparably to them (p = 0.267, 0.092, 0.332) in all classification tasks and effectively enhanced diagnostic accuracy for both junior and senior radiologists when used as an assistive tool.

CONCLUSION: ST-USNet serves as an effective and practical decision support system for superficial STMs classification in clinical oncology, though multi-center prospective validation and continuous model updating are required before clinical deployment.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Wu, Wu, Li, et al. Development and Validation of a Convolutional Neural Network Framework Based on Ultrasound Imaging for Multi-Classification of Superficial Soft Tissue Masses. Acad Radiol. 2026. PMID: 42705922. doi:10.1016/j.acra.2026.08.092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。